Product Images Pramipexole Dihydrochloride

This is a label for Pramipexole Dihydrochloride Extended-Release Tablets. The medication's strength is 0.375 mg and it is to be taken once daily. The tablets should be stored at a temperature between 20°C to 25°C and should not be chewed, crushed or divided. Complete prescribing information can be found in the package insert. The medication should be kept out of reach of children. It is manufactured by CsiaHealbcare L1 and distributed by Zydus Pharmaceuticals (USA) Inc. in Peringon, 05534.*

This is a description of a medication called Pramipexole which is an extended-release tablet used once daily. The container holds 30 tablets and it is advised that they are swallowed whole and not chewed, crushed, or divided. The tablets contain 0.75 mg of pramipexole dinydrochloride and should be stored at 20°C to 25°C. It is distributed by Zydus Pharmaceuticals (USA) Inc. and manufactured by Cadila Healthcare Ltd.*

This appears to be drug information on a medication called Pramipexole. It contains instructions for use and storage of extended-release tablets. The tablets should not be crushed, chewed, or divided and must be stored at 20-25°C. The document also includes manufacturing information for Cadia Healthcare Ltd.*

This is a prescription drug labeled "Pramipexole Dihydrochloride Extended-Release Tablets" with each tablet containing 225mg of the active ingredient. The tablets come in a pack of 30, and should be stored at 20°C to 25°C. The packaging also mentions the manufacturer and distributor of the drug.*

This is a medication label for Gver Coding Template extended-release tablets containing 3mg of pramipexole dihydrochloride. The tablets must be swallowed whole and should not be chewed, crushed or divided. The recommended dosage is indicated on the package insert. The tablets must be stored between 20°C to 25°C (68°F fo 77°F) and should be protected from exposure to high humidity. It comes in a unit of use container and was manufactured by Cadila Healthcare Lid in India. The label indicates that it contains 30 tablets and was distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

This is a description of a medication called Pramipexole Dihydrochloride Extended-Release Tablets. Each tablet contains 3.75mg of Pramipexole Dihydrochloride. The usual dosage instructions are found in the package insert. The tablets should not be chewed, crushed or divided, and should be stored at 20°C to 25°C. They come in an original unit of use container that contains 30 tablets. It also includes the manufacturing company's details but does not provide instructions on usage or treatability of any specific condition.*

This is a medication in tablet form called Pramipexole Dihydrochloride Extended-Release. Each extended-release tablet contains 45 mg of pramipexole dihydrochloride monohydrate equivalent to 4.23 mg of pramipexole dihydrochloride. The tablets must not be chewed, crushed, or divided and must be stored at a temperature range of 20°C to 25°C (68°F to 77°F) to protect from high humidity. The package comes with 30 tablets that must be dispensed in the original unit of use container. For complete prescribing information and usual dosage, one must refer to the package insert. This drug must also be kept out of the reach of children. It has been manufactured by Cada Healthare Lid in Ahmedabad, India, and marketed by Zydus Pharmaceuticals (USA) Inc. in Washington, NJ 08534.*